NCT03254849View on ClinicalTrials.gov

Empagliflozin and Sympathetic Nerve Traffic

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

April 20, 2020

Study Completion Date

April 20, 2020

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Empagliflozin

1 tablet

DRUG

Hydrochlorothiazide 25 mg

1 tablet

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

All Listed Sponsors
lead

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

NCT03254849 - Empagliflozin and Sympathetic Nerve Traffic | Biotech Hunter | Biotech Hunter